Innovation City: Emerging with the Innovation Award was Akston Biosciences Corp., which proposes once-a-week insulin injections for diabetic cats and dogs.
Purdue University and Akston Biosciences Bring “First Dose of Hope” in New Cancer Immunotherapy Trial for Dogs with Urinary Bladder Cancer
Energesis and Akston Biosciences Sign Partnership Agreement for Companion Animal Obesity Drug Development
An antigen-specific immunotherapeutic, AKS-107, deletes insulin-specific B cells and prevents murine autoimmune diabetes
Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine
